# Cholinergic Health After Menopause (CHAMP)

> **NCT04129060** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Vermont** · enrollment: 120 (actual)

## Conditions studied

- Postmenopausal Symptoms
- Aging
- Alzheimer Disease

## Interventions

- **DRUG:** Cholinergic antagonist

## Key facts

- **NCT ID:** NCT04129060
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-15
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04129060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04129060, "Cholinergic Health After Menopause (CHAMP)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04129060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*